Prevention of peptic ulceration in patients receiving NSAIDs

Non-steroidal anti-inflammatory drugs are widely prescribed and a minority of patients taking them will develop peptic ulceration with the risk of haemorrhage, perforation and death. Recent studies have identified which anti-ulcer agents will prevent such ulceration. This article discusses the problem, how to prevent it and which patients should receive prophylactic treatment.